Health Exchange: What to look for in Gilead earnings

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 28 April, 2015 by The TZ Newswire Staff

Health Exchange: What to look for in Gilead earnings

How much of a role will the blockbuster Hepatitis C drugs, Sovaldi and Harvoni, play in Gilead’s first-quarter results when the company reports earnings Thursday?
<

See also
- Next Article Write-Offs: 4.28.15
- Previous Article The Tell: S&P 500 may have hit its peak, bearish chart pattern warns
Editorial Calender

April 2015

M T W T F S S

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30

« Mar May »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 28 April, 2015 by The TZ Newswire Staff

Health Exchange: What to look for in Gilead earnings

See also

Editorial Calender

Recent Tags